DE69519748D1 - Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren - Google Patents
Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexierenInfo
- Publication number
- DE69519748D1 DE69519748D1 DE69519748T DE69519748T DE69519748D1 DE 69519748 D1 DE69519748 D1 DE 69519748D1 DE 69519748 T DE69519748 T DE 69519748T DE 69519748 T DE69519748 T DE 69519748T DE 69519748 D1 DE69519748 D1 DE 69519748D1
- Authority
- DE
- Germany
- Prior art keywords
- peptede
- antique
- repellent
- preparations
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/217,186 US5585461A (en) | 1994-03-24 | 1994-03-24 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
US08/261,160 US5591430A (en) | 1994-03-24 | 1994-06-17 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
US08/290,381 US5851523A (en) | 1994-03-24 | 1994-08-15 | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof |
PCT/US1995/003657 WO1995025740A1 (en) | 1994-03-24 | 1995-03-22 | Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69519748D1 true DE69519748D1 (de) | 2001-02-01 |
DE69519748T2 DE69519748T2 (de) | 2001-10-18 |
Family
ID=27396385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69519748T Expired - Lifetime DE69519748T2 (de) | 1994-03-24 | 1995-03-22 | Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren |
Country Status (16)
Country | Link |
---|---|
US (1) | US5851523A (de) |
EP (2) | EP0804483B1 (de) |
JP (1) | JP3536179B2 (de) |
CN (1) | CN1151170C (de) |
AT (1) | ATE198336T1 (de) |
AU (1) | AU698781B2 (de) |
CA (1) | CA2186004C (de) |
DE (1) | DE69519748T2 (de) |
DK (1) | DK0804483T3 (de) |
ES (1) | ES2154728T3 (de) |
FI (1) | FI963779A0 (de) |
GR (1) | GR3035636T3 (de) |
NO (1) | NO963919L (de) |
NZ (1) | NZ283587A (de) |
PT (1) | PT804483E (de) |
WO (1) | WO1995025740A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723832B1 (en) * | 1996-10-03 | 2004-04-20 | Ludwig Institute For Cancer Research | Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
US5686068A (en) * | 1994-03-24 | 1997-11-11 | Ludwig Institute For Cancer Research | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
US5587289A (en) * | 1995-03-14 | 1996-12-24 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof |
US5821122A (en) * | 1995-06-07 | 1998-10-13 | Inserm (Institute Nat'l De La Sante Et De La Recherche . .) | Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof |
EP0785274B1 (de) * | 1996-01-18 | 2000-09-27 | Aventis Pharma Deutschland GmbH | In kunstlisches Rekombinantes Substrat rAGG-1 und nativem Aggrecan zum Studium der proteolytischen Wirkung von 'Aggrecanase' in Zellkultursystemen |
EP1012173B1 (de) * | 1997-06-23 | 2007-10-31 | Ludwig Institute For Cancer Research | Isolierte decapeptide, die an hla moleküle binden, sowie deren verwendung |
US6060284A (en) * | 1997-07-25 | 2000-05-09 | Schering Corporation | DNA encoding interleukin-B30 |
US6291430B1 (en) | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
US6716809B1 (en) | 1997-09-12 | 2004-04-06 | Ludwig Institute For Cancer Research | Mage-A3 peptides presented by HLA class molecules |
US5965535A (en) | 1997-09-12 | 1999-10-12 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
GB9826143D0 (en) * | 1998-11-27 | 1999-01-20 | Ludwig Inst Cancer Res | Tumour rejection antigens |
US7090847B1 (en) * | 1999-09-09 | 2006-08-15 | Schering Corporation | Mammalian cytokines; related reagents and methods |
EP1905832A3 (de) * | 1999-09-09 | 2009-09-09 | Schering Corporation | Säuger Interleukin-12 P40 und Interleukin B30, Antikörper, Verwendungen in pharmazeutischen Zusammenstellungen |
JP4505166B2 (ja) * | 1999-09-09 | 2010-07-21 | シェーリング コーポレイション | 哺乳動物インターロイキン−12p40およびインターロイキンb30、その組成物、抗体、薬学的組成物における使用 |
US6897288B1 (en) | 1999-10-19 | 2005-05-24 | Ludwig Institute For Cancer Research | Mage-A12 antigenic peptides and uses thereof |
KR20020047249A (ko) * | 1999-10-19 | 2002-06-21 | 에드워드 에이. 맥더모트, 주니어 | Mage-a12 항원성 펩티드 및 그의 용도 |
AU5810201A (en) | 2000-05-10 | 2001-11-20 | Aventis Pasteur | Immunogenic polypeptides encoded by mage minigenes and uses thereof |
US7049413B2 (en) | 2001-05-18 | 2006-05-23 | Ludwig Institute For Cancer Research | MAGE-A3 peptides presented by HLA class II molecules |
US20030113919A1 (en) * | 2001-08-17 | 2003-06-19 | Aventis Pasteur, Ltd. | Immunogenic targets for melanoma |
EP1496939B1 (de) | 2002-04-09 | 2007-08-15 | Sanofi Pasteur Limited | Modifizierte cea nucleinsäure und expressionsvektoren |
AU2004280608B2 (en) * | 2002-04-09 | 2012-04-05 | Sanofi Pasteur, Inc. | Modified CEA/B7 vector |
US20040223949A1 (en) * | 2002-10-22 | 2004-11-11 | Sunnybrook And Women's College Health Sciences Center Aventis Pasteur, Ltd. | Vaccines using high-dose cytokines |
WO2009046827A2 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
CN106117334B (zh) * | 2016-06-24 | 2020-02-11 | 秦皇岛未名健康城开发有限公司 | 一种肿瘤抗原mage3的ctl识别表位肽及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342774A (en) * | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
CA2141960A1 (en) * | 1992-08-07 | 1994-02-17 | Ralph T. Kubo | Hla binding peptides and their uses |
US5519117A (en) * | 1992-12-22 | 1996-05-21 | Ludwig Institute For Cancer Research | Isolated, tyrosinase derived peptides and uses thereof |
ATE466869T1 (de) * | 1993-03-05 | 2010-05-15 | Epimmune Inc | Verfahren zur herstellung von immunogenen hla- a2.1-bindenden peptiden |
-
1994
- 1994-08-15 US US08/290,381 patent/US5851523A/en not_active Expired - Lifetime
-
1995
- 1995-03-22 NZ NZ283587A patent/NZ283587A/en not_active IP Right Cessation
- 1995-03-22 AT AT95914838T patent/ATE198336T1/de active
- 1995-03-22 EP EP95914838A patent/EP0804483B1/de not_active Expired - Lifetime
- 1995-03-22 ES ES95914838T patent/ES2154728T3/es not_active Expired - Lifetime
- 1995-03-22 DK DK95914838T patent/DK0804483T3/da active
- 1995-03-22 EP EP99200031A patent/EP0960622A3/de not_active Withdrawn
- 1995-03-22 AU AU21928/95A patent/AU698781B2/en not_active Expired
- 1995-03-22 CN CNB951922610A patent/CN1151170C/zh not_active Expired - Lifetime
- 1995-03-22 JP JP52482295A patent/JP3536179B2/ja not_active Expired - Lifetime
- 1995-03-22 WO PCT/US1995/003657 patent/WO1995025740A1/en active IP Right Grant
- 1995-03-22 PT PT95914838T patent/PT804483E/pt unknown
- 1995-03-22 DE DE69519748T patent/DE69519748T2/de not_active Expired - Lifetime
- 1995-03-22 CA CA002186004A patent/CA2186004C/en not_active Expired - Lifetime
-
1996
- 1996-09-19 NO NO963919A patent/NO963919L/no unknown
- 1996-09-23 FI FI963779A patent/FI963779A0/fi unknown
-
2001
- 2001-03-26 GR GR20010400481T patent/GR3035636T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI963779A (fi) | 1996-09-23 |
WO1995025740A1 (en) | 1995-09-28 |
NO963919L (no) | 1996-11-20 |
CN1151170C (zh) | 2004-05-26 |
EP0804483B1 (de) | 2000-12-27 |
DK0804483T3 (da) | 2001-02-12 |
CA2186004C (en) | 2008-09-23 |
EP0804483A4 (de) | 1998-05-20 |
FI963779A0 (fi) | 1996-09-23 |
NO963919D0 (no) | 1996-09-19 |
CA2186004A1 (en) | 1995-09-28 |
US5851523A (en) | 1998-12-22 |
JP3536179B2 (ja) | 2004-06-07 |
GR3035636T3 (en) | 2001-06-29 |
AU2192895A (en) | 1995-10-09 |
DE69519748T2 (de) | 2001-10-18 |
JPH10504518A (ja) | 1998-05-06 |
CN1150805A (zh) | 1997-05-28 |
PT804483E (pt) | 2001-06-29 |
ES2154728T3 (es) | 2001-04-16 |
EP0960622A2 (de) | 1999-12-01 |
AU698781B2 (en) | 1998-11-05 |
NZ283587A (en) | 1998-04-27 |
EP0804483A1 (de) | 1997-11-05 |
EP0960622A3 (de) | 1999-12-22 |
ATE198336T1 (de) | 2001-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69519748T2 (de) | Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren | |
NZ335485A (en) | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | |
TW327194B (en) | Novel amyloid precursor proteins and methods of using same | |
CY1110868T1 (el) | Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση | |
DE69824719D1 (de) | Cytokinähnlicher faktor-7 aus säugetieren | |
DE3681426D1 (de) | Mittel zur oralen hygiene. | |
DE69637807D1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
ES545725A0 (es) | Procedimiento para preparar peptidos de interferon | |
ATE279441T1 (de) | Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen | |
ATE171212T1 (de) | Corticotropin freisetzende rezeptoren des faktor 2 | |
WO1999061618A3 (en) | Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
ATE213776T1 (de) | (s)-hydroxynitrillyase aus hevea brasiliensis | |
ATE286123T1 (de) | Klonierung von pheromon rezeptoren aus vertebraten und deren verwendungen | |
EP0990703A4 (de) | Neues polypeptid, dafür kodierende dna und deren verwendungen | |
DE69737476D1 (de) | Neuer galaninrezeptor | |
ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
PE20399A1 (es) | Muteina ob | |
EP1026237A3 (de) | Proteinkinase von Ton und Neurofilament PK40 und PK36 | |
DE60026666D1 (de) | Induktion von antigen-spezifischen T-Zellen durch Interferon | |
ATE439368T1 (de) | Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung | |
GB2283974A (en) | Allatostatins and their use | |
ATE283358T1 (de) | Protease-ähnliches protein | |
SE9604439D0 (sv) | New receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: LUDWIG INSTITUTE FOR CANCER RESEARCH, NEW YORK, N. |
|
8364 | No opposition during term of opposition |